Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Clinical diagnosis of liver disease

II. Circulatory involvement, fluid imbalance, and mental changes

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Kelty, R. H., Baggenstoss, A. H., andButt, H. R. Relation of regenerated liver nodule to vascular bed in cirrhosis.Gastroenterology 15: 285, 1950.

  2. 2.

    Jahnke, E. J., Jr., Palmer, E. D., andBrick, I. B. The Cruveilhier-Baumgarten syndrome: A review and report of four cases, three treated by direct portacaval shunt.Ann. Surg. 140: 44, 1954.

  3. 3.

    Rack, F. R., Mincks, J. R., andSimeone, F. A. Observations on etiology of esophageal varices.A.M.A. Arch. Surg. 65: 422, 1952.

  4. 4.

    Palmer, E. D., andBrick, I. B. Esophageal varices in non-cirrhotic patients.Am. J. Med. 17: 641, 1954.

  5. 5.

    Reynolds, T. B., Balfour, D. C., Jr., Levinson, D. C., Mikkelsen, W. P., andPattison, A. C. Comparison of wedged hepatic vein pressure with portal vein pressure in human subjects with cirrhosis.J. Clin. Invest. 34: 213, 1955.

  6. 6.

    Lipp, W. F., andLipsitz, M. H. The clinical significance of the co-existence of peptic ulcer and portal cirrhosis with special reference to the problem of massive hemorrhage.Gastroenterology 22: 181, 1952.

  7. 7.

    Palmer, E. D. The Esophagus and Its Diseases. New York, Hoeber, 1952.

  8. 8.

    Dameshek, W. Hypersplenism.Bull. New York Acad. Med. 31: 113, 1955.

  9. 9.

    Doan C. A. Hypersplenism.Bull. New York Acad. Med. 25: 625, 1949.

  10. 10.

    Goldblatt H. Studies in experimental hypertension: Production of malignant phase of hypertension.J. Exper. Med. 67: 809, 1938.

  11. 11.

    Shorr, E., Zweifach, B. W., Furchgott, D. F., andBaez, S. Hepatorenal factors in circulatory homeostasis: Tissue origins of vasotropic principles, VEM and VDM, which appear during evolution of hemorrhagic and tourniquet shock.Circulation 3: 42, 1951.

  12. 12.

    Spatt, S. D., andRosenblatt, P. Incidence of hypertension in portal cirrhosis; A study of 80 necropsied cases of portal cirrhosis.Ann. Int. Med. 31: 479, 1949.

  13. 13.

    Barr, D. P., Riss, E. M., andEder, H. A. Protein-lipid relationships in human plasma: II.In atherosclerosis and related conditions. Am. J. Med. 11: 480, 1951.

  14. 14.

    Gofman, J. W., Jones, H. B., Lindgred, F. T., Lyon, T. P., Elliott, H. A., andStrisower, B. Blood lipids and human atherosclerosis.Circulation 2: 161, 1950.

  15. 15.

    Glider, H., Redo, S. F., Barr, D., andChild, C. G. Water distribution in normal subjects and in patients with Laennec's cirrhosis.J. Clin. Invest. 33: 555, 1954.

  16. 16.

    Deane, N., Schreiner, G. E., andRobertson, J. S. The velocity of distribution of sucrose between plasma and interstitial fluid with reference to the use of sucrose for the measurement of sucrose in man.J. Clin. Invest. 30: 1463, 1952.

  17. 17.

    Berson, S. A. Blood volume in health and disease.Bull. New York Acad. Med. 30: 750, 1954.

  18. 18.

    Prentice, T. C., Siri, W., andJoiner, E. E. Quantitative studies of ascitic fluid circulation with tritium labeled water.Am. J. Med. 13: 668, 1952.

  19. 19.

    Eisenmenger, W. J. Role of sodium in the formation and control of ascites in patients with cirrhosis.Ann. Int. Med. 37: 261, 1952.

  20. 20.

    Hyatt, R. E., andSmith, J. R. The mechanism of ascites.Am. J. Med. 16: 434, 1954.

  21. 21.

    Madden, J. L., Lore, J. M., Gerold, F. P., andRavid, J. M. The pathogenesis of ascites and a consideration of its treatment.Surg. Gynec. Obst. 99: 385, 1954.

  22. 22.

    McKay, D. G., Sparling, H. J., Jr., andRobbins, S. L. Cirrhosis of liver with massive hydrothorax.Arch. Int. Med. 79: 501, 1947.

  23. 23.

    Leevy, C. M., andDonovan, F. Estimation of total circulating sodium.J. A. M. A., in press.

  24. 24.

    James, A. H., Brooks, L., Edelman, I. S., Olney, J. M., andMoore, F. D. Body sodium and potassium: I. Simultaneous measurement of exchangeable sodium and potassium in man by isotope dilution.Metabolism 3: 313, 1954.

  25. 25.

    Artman, E. L., andWise, R. A. Hypokalemia in liver cell failure.Am. J. Med. 15: 459, 1953.

  26. 26.

    Moore, F. D., Edelman, I. S., Olney, J. M., James, A.H., Brooks, L., andWilson, G. M. Body sodium and potassium: III. Inter-related trends in alimentary renal and cardiovascular disease; Lack of correlation between body stores and plasma concentration.Metabolism 3: 334, 1954.

  27. 27.

    Walshe, J. M. Observations on the symptomatology and pathogenesis of hepatic coma.Quart. J. Med. 20: 421, 1951.

  28. 28.

    Mann, J. D., Bollman, J. L., Huizengar, K. A., Farrar, T., andGrindlay, J. H. Blood ammonia: Experimental and clinical study in abnormalities of the liver and portal circulation.Gastroenterology 27: 399, 1954.

  29. 29.

    White, L. P., Phear, E. A., Summerskill, W. H. J., andSherlock, S. Ammonium tolerance in liver disease: Observations based on catheterization of the hepatic veins.J. Clin. Invest. 34: 158, 1955.

  30. 30.

    Gabuzda, G. J., Jr., Phillips, G. B., andDavidson, C. S. Reversible toxic manifestations in patients with cirrhosis of the liver given cation-xchange resins.New England J. Med. 246: 124, 1952.

  31. 31.

    Butt, H. R., Amatuzio, D. S., Bollman, J. L., Gabuzda, G. J., Giges, B., Sborov, V. M., andSeligson, D. Panel discussion: The clinical and biochemical features of hepatic insufficiency.Gastroenterology 25: 471, 1953.

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Leevy, C.M. Clinical diagnosis of liver disease. Digest Dis Sci 1, 526–537 (1956). https://doi.org/10.1007/BF02236126

Download citation

Keywords

  • Public Health
  • Liver Disease
  • Clinical Diagnosis